GRIFOLS SA INH. A EO-,25/ ES0171996087 /
| 5/17/2024 8:38:01 AM | Chg. -0.2290 | Volume | Bid7:23:53 PM | Ask7:23:53 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 9.8760EUR | -2.27% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 8.1 bill.EUR | - | 109.84 |
GlobeNewswire
4/18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
4/4
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
11/15/2023
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...
